These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19555384)

  • 1. The impact of lymph node yield on Duke's B and C colorectal cancer survival.
    Fretwell VL; Ang CW; Tweedle EM; Rooney PS
    Colorectal Dis; 2010 Oct; 12(10):995-1000. PubMed ID: 19555384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors affecting survival in stage II colorectal cancer: is lymph node harvesting relevant?
    Peeples C; Shellnut J; Wasvary H; Riggs T; Sacksner J
    Dis Colon Rectum; 2010 Nov; 53(11):1517-23. PubMed ID: 20940600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
    Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
    Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
    Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
    Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of mutant p53 protein in regional lymph nodes is associated with adverse outcome in stage II colorectal cancer.
    Clarke G; Ryan E; Crowe J; O'Keane JC; MacMathúna P
    Eur J Histochem; 1999; 43(4):311-6. PubMed ID: 10682269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.
    Cianchi F; Palomba A; Boddi V; Messerini L; Pucciani F; Perigli G; Bechi P; Cortesini C
    World J Surg; 2002 Mar; 26(3):384-9. PubMed ID: 11865379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ratio of metastatic to resected lymph nodes as a prognostic factor in node-positive colorectal cancer.
    Huh JW; Kim YJ; Kim HR
    Ann Surg Oncol; 2010 Oct; 17(10):2640-6. PubMed ID: 20300967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of risk factors associated with lymph node metastasis and prognosis of T1-2 colorectal cancer].
    Chai R; Fu CG; Wang H; Liu LJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Apr; 14(4):245-8. PubMed ID: 21538263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease.
    Evans MD; Barton K; Rees A; Stamatakis JD; Karandikar SS
    Colorectal Dis; 2008 Feb; 10(2):157-64. PubMed ID: 17477849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association between the number of retrieved lymph nodes in stage II( colorectal cancer radical resection and its prognosis].
    Zhang XM; Zhou ZX; Liang JW; Wang Z; Bi JJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Apr; 13(4):260-2. PubMed ID: 20422479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons.
    Vaccaro CA; Im V; Rossi GL; Quintana GO; Benati ML; Perez de Arenaza D; Bonadeo FA
    Dis Colon Rectum; 2009 Jul; 52(7):1244-50. PubMed ID: 19571700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathological characteristics and prognosis of patients with recurrent colorectal cancer].
    Song XM; Yang ZL; Wang L; Wang JP; Zhan WH; He YL; Huang YH; Lan P
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):492-4. PubMed ID: 17143792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ratio of metastatic to resected lymph nodes enhances to predict survival in patients with stage III colorectal cancer.
    Qiu HB; Zhang LY; Li YF; Zhou ZW; Keshari RP; Xu RH
    Ann Surg Oncol; 2011 Jun; 18(6):1568-74. PubMed ID: 21207155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A paradox explained? Patients with delayed diagnosis of symptomatic colorectal cancer have good prognosis.
    Rupassara KS; Ponnusamy S; Withanage N; Milewski PJ
    Colorectal Dis; 2006 Jun; 8(5):423-9. PubMed ID: 16684087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis.
    Laurent C; Sa Cunha A; Rullier E; Smith D; Rullier A; Saric J
    J Am Coll Surg; 2004 Jun; 198(6):884-91. PubMed ID: 15194069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.
    Sarli L; Bader G; Iusco D; Salvemini C; Mauro DD; Mazzeo A; Regina G; Roncoroni L
    Eur J Cancer; 2005 Jan; 41(2):272-9. PubMed ID: 15661553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
    Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
    Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.